Jubilant Pharmova Ltd
STALWARTLOWHealthcareBSE: 530019NSE: JUBLPHARMA
Final Score
80/100
Geometric mean of 5 dimension scores
ClassificationQUANT
STRONG LONG
Overall Rank
#71
Sector Rank
#8
Healthcare
Price-to-Earnings Ratioi
29×
≈ sector 30.4×
Return on Capital Employedi
9.5%
▼ vs sector 14%
Return on Equityi
9.6%
▼ vs sector 12.7%
Piotroski F-Scorei
8/9
Market Capitalizationi
₹13.4K Cr
▲ vs sector ₹1.1K Cr
Dividend Yieldi
0.6%
▲ vs sector 0%
Catalysts
- +Company has reduced debt.
- +Company's working capital requirements have reduced from 43.0 days to 16.3 days
Risks
- −The company has delivered a poor sales growth of 3.90% over past five years.
- −Company has a low return on equity of 1.41% over last 3 years.
- −Company might be capitalizing the interest cost
- −Promoter holding has decreased over last 3 years: -3.01%